RxDoctor Payments Data

John Giurini, DPM

Podiatrist · Boston, MANPI 1013956309

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (47.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Kairos Surgical Inc at 29.9% of the total. Reporting peaked in 2020 at $2,054 and has fallen 61.4% since, to $793 in 2025.

$5,582in general payments, 2019–2025

Across 56 payments — averaging $99.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kairos Surgical Inc$2K
  • Arthrex$1K
  • Integra Lifesciences Corporation$685
  • Stryker$413
  • Lifenet Health$390
  • Smith+Nephew$234
  • plus $725 from 9 others

What the payments were for

  • Travel & lodging$4318%
  • Food & beverage$2,14738%
  • Education$2,64247%
  • Other$3626%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,582 in reported general payments places this provider in the 85th percentile of 179 podiatrist providers in Massachusetts.

See all podiatrist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$124,303
Medicare patients
382
Services billed
1,237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav39$333
Piroxicam18$252
Doxycycline Hyclate16$72
Cephalexin12$40

Paid to pharmacies, not to this prescriber.

Other podiatrist in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →